MAP PHARMACEUTICALS, INC. Forms 3, 4 and 5: Stock Options
Statements of beneficial ownership filed with the SEC by officers, directors and 10% owners: 28 rows in 2009. Transaction codes are the SEC's. Shares and prices are split-adjusted; the as-filed figure is underneath.
- 2009-12-14: Reporting owner ARMER THOMAS A; Form 4; Security Stock Option (Right to Buy); Transaction M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3.
- 2009-12-01: Reporting owner GIANAKAKOS ANASTASIOS; Form 4; Security Stock Option (Right to Buy); Transaction M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3.
- 2009-11-18: Reporting owner HENWOOD GERALDINE; Form 4; Security Stock Option (Right to Buy); Transaction M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3.
- 2009-11-02: Reporting owner GIANAKAKOS ANASTASIOS; Form 4; Security Stock Option (Right to Buy); Transaction M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3.
| Transaction date | Reporting owner | Form | Security | Transaction | Shares | Price | Price that day | Filing |
|---|---|---|---|---|---|---|---|---|
| 2009-12-14 | ARMER THOMAS A Director, Officer (Chief Scientific Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −10,000 40,847 owned after | $3.36 exercise price | 2009-12-16 | |
| 2009-12-01 | GIANAKAKOS ANASTASIOS Officer (SVP, Cor & Business Dev) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −4,500 48,643 owned after | $0.74 exercise price | 2009-12-02 | |
| 2009-11-18 | HENWOOD GERALDINE Director | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −16,250 1,627 owned after | $0.64 exercise price | 2009-11-19 | |
| 2009-11-02 | GIANAKAKOS ANASTASIOS Officer (SVP, Cor & Business Dev) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −4,500 53,143 owned after | $0.74 exercise price | 2009-11-04 | |
| 2009-11-02 | CHAI CHRISTOPHER Y Officer (Chief Financial Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −10,000 119,122 owned after | $0.74 exercise price | 2009-11-04 | |
| 2009-10-01 | GIANAKAKOS ANASTASIOS Officer (SVP, Cor & Business Dev) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −4,500 57,643 owned after | $0.74 exercise price | 2009-10-05 | |
| 2009-10-01 | CHAI CHRISTOPHER Y Officer (Chief Financial Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −10,000 129,122 owned after | $0.74 exercise price | 2009-10-05 | |
| 2009-09-08 | GIANAKAKOS ANASTASIOS Officer (SVP, Cor & Business Dev) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −4,500 62,143 owned after | $0.74 exercise price | 2009-09-10 | |
| 2009-07-10 | GIANAKAKOS ANASTASIOS Officer (SVP, Cor & Business Dev) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −25,000 66,643 owned after | $0.74 exercise price | 2009-07-14 | |
| 2009-05-27 | ARMER THOMAS A Director, Officer (Chief Scientific Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −60,000 35,846 owned after | $0.74 exercise price | 2009-05-28 | |
| 2009-05-21 | Soros Robert | SOROS JONATHAN T ALLAN | SOROS FUND MANAGEMENT LLC | SOROS GEORGE 10% Owner | 10% Owner | 10% Owner | 10% Owner | 4 | Stock Option (right to buy) Derivative · Indirect · See footnotes | J Other acquisition or disposition (describe transaction) | +7,500 7,500 owned after | $3.18 exercise price | 2010-02-16 | |
| 2009-05-21 | Soros Robert | SOROS FUND MANAGEMENT LLC | SOROS JONATHAN T ALLAN | SOROS GEORGE 10% Owner | 10% Owner | 10% Owner | 10% Owner | 4 | Stock Option (right to buy) Derivative · Indirect · See footnotes | J Other acquisition or disposition (describe transaction) | +7,500 7,500 owned after | $3.18 exercise price | 2009-05-26 | |
| 2009-05-21 | PEARL FRANK H 10% Owner | 4 | Stock Option (Right to Buy) Derivative · Indirect · See footnotes | J Other acquisition or disposition (describe transaction) | +7,500 7,500 owned after | $3.18 exercise price | 2009-05-26 | |
| 2009-05-21 | Freund John Gordon Director | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | −7,500 7,500 owned after | $3.18 exercise price | 2009-05-22 | |
| 2009-05-21 | GOLDFISCHER CARL Director | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | −7,500 7,500 owned after | $3.18 exercise price | 2009-05-22 | |
| 2009-05-21 | Wolff Henry Ward Director | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | −7,500 7,500 owned after | $3.18 exercise price | 2009-05-22 | |
| 2009-05-21 | KELLEY BERNARD J Director | 4 | Stock Option (right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | −7,500 7,500 owned after | $3.18 exercise price | 2009-05-22 | |
| 2009-05-21 | HENWOOD GERALDINE Director | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | −7,500 7,500 owned after | $3.18 exercise price | 2009-05-22 | |
| 2009-05-21 | WARD SCOTT R Director | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | −7,500 7,500 owned after | $3.18 exercise price | 2009-05-22 | |
| 2009-05-21 | MCPHERRON MATTHEW V Director, 10% Owner | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +7,500 7,500 owned after | $3.18 exercise price | 2009-05-22 | |
| 2009-02-11 | ARMER THOMAS A Director, Officer (CSO, Director) | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +75,000 75,000 owned after | $10.37 | 2009-02-13 | |
| 2009-02-11 | CHAI CHRISTOPHER Y Officer (Chief Financial Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +75,000 75,000 owned after | $10.37 | 2009-02-13 | |
| 2009-02-11 | Friedman Charlene A Officer (VP President, Gen Counsel &Sec) | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +75,000 75,000 owned after | $10.37 | 2009-02-13 | |
| 2009-02-11 | KELLERMAN DONALD J Officer (SVP,Clinical Dev & Med Affairs) | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +35,000 35,000 owned after | $10.37 | 2009-02-13 | |
| 2009-02-11 | NELSON TIMOTHY S Director, Officer (President and CEO, Director) | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +175,000 175,000 owned after | $10.37 | 2009-02-13 | |
| 2009-02-11 | GIANAKAKOS ANASTASIOS Officer (SVP, Cor & Business Dev) | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +100,000 100,000 owned after | $10.37 | 2009-02-13 | |
| 2009-02-09 | CHAI CHRISTOPHER Y Officer (Chief Financial Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −21 139,122 owned after | $0.74 exercise price | 2009-02-11 | |
| 2009-02-04 | GIANAKAKOS ANASTASIOS Officer (SVP, Cor & Business Dev) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −15,000 91,643 owned after | $0.74 exercise price | 2009-02-05 |